Vimarsana
Biggest News Aggregation in the World

Michaela Dinerman News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Michaela Dinerman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Michaela Dinerman Today - Breaking & Trending Today

Viking Therapeutics (NASDAQ:VKTX) Trading Down 4.4% - Vimarsana News

Viking Therapeutics (NASDAQ:VKTX) Trading Down 4.4%

Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Rating) dropped 4.4% on Monday . The company traded as low as $23.17 and last traded at $23.19. Approximately 1,773,898 shares were traded during trading, a decline of 50% from the average daily volume of 3,562,957 shares. The stock had previously closed at $24.27. Wall Street Analysts […]

Source: wkrb13.com
100,000 Shares in Viking Therapeutics, Inc. (NASDAQ:VKTX) Bought by Moore Capital Management LP - Vimarsana News

100,000 Shares in Viking Therapeutics, Inc. (NASDAQ:VKTX) Bought by Moore Capital Management LP

Moore Capital Management LP bought a new position in Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Rating) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 100,000 shares of the biotechnology company’s stock, valued at approximately $940,000. Moore Capital Management LP owned 0.13% […]

Viking Therapeutics (NASDAQ:VKTX) Trading Up 3.7% - Vimarsana News

Viking Therapeutics (NASDAQ:VKTX) Trading Up 3.7%

Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Rating) rose 3.7% during mid-day trading on Wednesday . The company traded as high as $21.49 and last traded at $21.41. Approximately 793,171 shares were traded during mid-day trading, a decline of 78% from the average daily volume of 3,674,765 shares. The stock had previously closed at $20.64. Wall […]

Source: wkrb13.com
Viking Therapeutics, Inc. (NASDAQ:VKTX) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - Vimarsana News

Viking Therapeutics, Inc. (NASDAQ:VKTX) Receives Consensus Recommendation of "Moderate Buy" from Brokerages

Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Rating) has been assigned an average recommendation of “Moderate Buy” from the nine research firms that are currently covering the firm, MarketBeat.com reports. One research analyst has rated the stock with a sell recommendation and four have issued a buy recommendation on the company. The average twelve-month target price […]

Viking Therapeutics (NASDAQ:VKTX) Price Target Increased to $37.00 by Analysts at Raymond James - Vimarsana News

Viking Therapeutics (NASDAQ:VKTX) Price Target Increased to $37.00 by Analysts at Raymond James

Viking Therapeutics (NASDAQ:VKTX – Get Rating) had its target price hoisted by Raymond James from $35.00 to $37.00 in a report published on Wednesday morning, The Fly reports. Other research analysts also recently issued research reports about the stock. Truist Financial upped their price objective on shares of Viking Therapeutics from $28.00 to $32.00 and […]